Alnylam Pharmaceuticals, Inc.
ALNY Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of ALNY by members of U.S. Congress
ALNY Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
ALNY Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
ALNY Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in ALNY holdings by institutional investors
Quarterly net insider trading by ALNY's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$450,000 Jul 20, 2026 Issue: Pharmacy Medicare/Medicaid Trade (domestic/foreign)
-
$430,000 Apr 20, 2026 Issue: Medicare/Medicaid Trade (domestic/foreign) Pharmacy
-
$390,000 Jan 20, 2026 Issue: Pharmacy Medicare/Medicaid Trade (domestic/foreign)
-
$390,000 Oct 20, 2025 Issue: Medicare/Medicaid Trade (domestic/foreign) Pharmacy
-
$390,000 Jul 20, 2025 Issue: Medicare/Medicaid Trade (domestic/foreign)
-
$440,000 Apr 21, 2025 Issue: Medicare/Medicaid Veterans
-
$500,000 Jan 21, 2025 Issue: Medicare/Medicaid Veterans
-
$480,000 Oct 21, 2024 Issue: Veterans Medicare/Medicaid
-
$480,000 Jul 22, 2024 Issue: Veterans Medicare/Medicaid
-
$220,000 Jan 22, 2024 Issue: Medicare/Medicaid
-
$220,000 Oct 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$60,000 Jul 14, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Medicare/Medicaid
-
$100,000 Jan 14, 2023 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$60,000 Oct 16, 2022 Issue: None
-
$50,000 Jul 20, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$50,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$60,000 Jul 15, 2022 Issue: None
-
$40,000 Jul 15, 2022 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$40,000 Apr 15, 2022 Issue: None
-
$40,000 Apr 14, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Jan 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2022 Issue: Medicare/Medicaid
-
$40,000 Jan 13, 2022 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 15, 2021 Issue: Medicare/Medicaid Health Issues
-
$40,000 Oct 14, 2021 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$40,000 Jul 13, 2021 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$30,000 Apr 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$40,000 Apr 12, 2021 Issue: Medicare/Medicaid
-
$30,000 Jan 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 16, 2020 Issue: Medicare/Medicaid
-
$50,000 Oct 14, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 06, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2020 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$30,000 Jul 15, 2020 Issue: Medicare/Medicaid
-
$50,000 Jul 15, 2020 Issue: Medicare/Medicaid
-
$30,000 Jul 14, 2020 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 20, 2020 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2020 Issue: Medicare/Medicaid
-
$30,000 Apr 17, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Apr 17, 2020 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2020 Issue: Medicare/Medicaid
-
$50,000 Jan 21, 2020 Issue: Medicare/Medicaid
-
$60,000 Jan 17, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$50,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$40,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$20,000 Oct 21, 2019 Issue: Health Issues
-
$30,000 Jul 22, 2019 Issue: Medicare/Medicaid
-
$30,000 Jul 22, 2019 Issue: Health Issues
-
$50,000 Jul 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Jul 16, 2019 Issue: Medicare/Medicaid
-
$30,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Apr 22, 2019 Issue: Health Issues
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Jan 22, 2019 Issue: Health Issues
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2019 Issue: Health Issues
-
$40,000 Oct 22, 2018 Issue: Health Issues
-
$30,000 Oct 22, 2018 Issue: Medicare/Medicaid
-
$30,000 Oct 22, 2018 Issue: Health Issues
-
$30,000 Oct 19, 2018 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2018 Issue: Health Issues
-
$30,000 Jul 19, 2018 Issue: Health Issues
-
$40,000 Apr 20, 2018 Issue: Health Issues
-
$30,000 Apr 20, 2018 Issue: Health Issues
-
$20,000 Jan 22, 2018 Issue: Health Issues
-
$40,000 Jan 22, 2018 Issue: Health Issues
-
$40,000 Oct 20, 2017 Issue: Health Issues
-
$40,000 Jul 20, 2017 Issue: Health Issues
-
$30,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues
-
$40,000 Apr 20, 2017 Issue: Health Issues
-
$40,000 Jan 23, 2017 Issue: Health Issues
Former government officials who have lobbied for ALNY
39 former government officials from 25 congressional offices at 9 lobbying firms have lobbied for ALNY, most recently Jul 20, 2026.
-
Curtis Rhyne House Rep. Virginia Foxx (2008-2009), House Republican Study Committee (2009-2014), Rep. Richard Hudson (2014-2017), Rep. George Holding (2017-2020) -
Margaret Herman Senate New Legislative Aide, Senator Mark Warner (June 2017-May 2019); Legislative Assistant, Rep. Mikie Sherrill (May 2019-Jan. 2020); Senior LA, Rep. Dan Kildee (Jan. 2020-Dec. 2022) -
Sarah Egge Senate 1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction -
Amy Jensen Congress 1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Special Affairs
-
Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg -
Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie -
Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
-
Nicolas Magallanes House Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander
ALNY Estimated quarterly lobbying spending
ALNY Revenue by Segment or Geography
By Segment
By Geography
ALNY Income Statement
ALNY Balance Sheet
ALNY Cash Flow
U.S. Patents
New ALNY patent grants
-
Patent Title: Pegylated lipids and their use for drug delivery Jun. 19, 2018
-
Patent Title: Conserved hbv and hcv sequences useful for gene silencing May. 29, 2018
-
Patent Title: Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes May. 15, 2018
-
Patent Title: Gnaq targeted dsrna compositions and methods for inhibiting expression May. 08, 2018
-
Patent Title: Compositions and methods for inhibiting expression of mutant egfr gene May. 01, 2018
-
Patent Title: Compositions and methods directed to treating liver fibrosis Apr. 17, 2018
-
Patent Title: Compositions and methods for inhibiting expression of cd274/pd-l1 gene Apr. 03, 2018
-
Patent Title: Method and medicament for inhibiting the expression of a given gene Feb. 27, 2018
-
Patent Title: Serpina1 sirnas: compositions of matter and methods of treatment Jan. 30, 2018
-
Patent Title: Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene Jan. 16, 2018
-
Patent Title: Carbohydrate conjugates as delivery agents for oligonucleotides Jan. 16, 2018
-
Patent Title: Complement component c5 irna compositions and methods of use thereof Dec. 26, 2017
-
Patent Title: Compositions and methods for inhibiting expression of the pcsk9 gene Nov. 21, 2017
-
Patent Title: Modified rnai agents Oct. 24, 2017
-
Patent Title: Tmprss6 irna compositions and methods of use thereof Oct. 10, 2017
-
Patent Title: Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Sep. 26, 2017
-
Patent Title: Compositions and methods for inhibition of expression of protein c (proc) genes Aug. 08, 2017
-
Patent Title: Therapeutic compositions Jul. 18, 2017
-
Patent Title: Modified rnai agents Jul. 18, 2017
-
Patent Title: Complement component c5 irna compositions and methods of use thereof Jul. 11, 2017
-
Patent Title: Di-aliphatic substituted pegylated lipids Jul. 11, 2017
-
Patent Title: Nucleic acid lipid particle formulations Jun. 27, 2017
-
Patent Title: Biodegradable lipids for the delivery of active agents Jun. 20, 2017
-
Patent Title: Compositions and methods for inhibiting expression of the alas1 gene Apr. 25, 2017
-
Patent Title: Compositions and methods for inhibiting expression of a target gene Mar. 07, 2017
-
Patent Title: Serapina1 irna compositions and methods of use thereof Feb. 21, 2017
-
Patent Title: Monomers and oligonucleotides comprising cycloaddition adduct(s) Feb. 14, 2017
-
Patent Title: Gnaq targeted dsrna compositions and methods for inhibiting expression Feb. 14, 2017
-
Patent Title: Oligonucleotide end caps Dec. 06, 2016
-
Patent Title: Compositions and methods for inhibiting expression of the hamp gene Nov. 29, 2016
-
Patent Title: Irna agents with biocleavable tethers Oct. 25, 2016
-
Patent Title: Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents Oct. 11, 2016
-
Patent Title: Ligand-conjugated monomers Sep. 27, 2016
-
Patent Title: Nucleic acid chemical modifications Sep. 27, 2016
-
Patent Title: Compositions and methods for inhibiting expression of factor v Sep. 13, 2016
-
Patent Title: Compositions and methods for inhibiting expression of cd274/pd-l1 gene Aug. 23, 2016
-
Patent Title: Stable non-aggregating nucleic acid lipid particle formulations Aug. 16, 2016
-
Patent Title: Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases Jul. 26, 2016
-
Patent Title: Modified irna agents Jul. 19, 2016
-
Patent Title: Serpinc1 irna compositions and methods of use thereof Jun. 28, 2016
-
Patent Title: Carbohydrate conjugates as delivery agents for oligonucleotides Jun. 21, 2016
-
Patent Title: Carbohydrate conjugates as delivery agents for oligonucleotides Jun. 21, 2016
-
Patent Title: Carbohydrate conjugates as delivery agents for oligonucleotides May. 31, 2016
-
Patent Title: Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes May. 17, 2016
-
Patent Title: Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Apr. 26, 2016
-
Patent Title: Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes Apr. 19, 2016
-
Patent Title: Modified irna agents Mar. 22, 2016
-
Patent Title: Compositions and methods for inhibiting expression of the pcsk9 gene Feb. 16, 2016
-
Patent Title: Methods and compositions for delivery of active agents Feb. 09, 2016
-
Patent Title: Complement component c5 irna compositions and methods of use thereof Feb. 02, 2016
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded to ALNY from public contracts
ALNY News
Recent insights relating to ALNY
CNBC Recommendations
Recent picks made for ALNY stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ALNY
ALNY Analyst Ratings
ALNY Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
ALNY Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $ALNY stock a Buy, Sell, or Hold?
- What is the price target for $ALNY stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
ALNY Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $ALNY stock?
- Who owns the most shares of $ALNY stock?
- What funds own $ALNY stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
ALNY Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ALNY Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About ALNY
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
- Address Cambridge, MA
- Market Cap 33.7 billion
- Employees 2,500
- Industrial Classification Pharmaceutical Preparations
Alnylam Pharmaceuticals, Inc. (ALNY) Historical Stock Prices
Alnylam Pharmaceuticals, Inc. (ALNY) closed at $251.65 on September 22, 2026. Over the past year its adjusted close ranged from $205.48 to $491.22. Daily prices go back to January 2, 2014, 3,198 trading days in all.
- 1 month+6.53%
- 3 months-12.68%
- Year to date-36.72%
- 1 year-45.16%
- 3 years+46.69%
- 5 years+34.61%
- Max+294.07%
See every congressional and insider trade on the ALNY price chart
Quiver Premium charts ALNY's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | 246.86 | 255.51 | 244.13 | 251.65 | 251.65 | 1,131,952 |
| Sep 21, 2026 | 240.37 | 247.10 | 237.97 | 244.32 | 244.32 | 1,152,874 |
| Sep 18, 2026 | 246.41 | 246.49 | 238.51 | 239.56 | 239.56 | 2,756,178 |
| Sep 17, 2026 | 242.60 | 245.63 | 239.50 | 245.51 | 245.51 | 1,006,573 |
| Sep 16, 2026 | 239.50 | 242.24 | 236.00 | 239.36 | 239.36 | 853,903 |
| Sep 15, 2026 | 246.99 | 247.43 | 237.44 | 238.27 | 238.27 | 2,175,150 |
| Sep 14, 2026 | 250.16 | 252.79 | 244.18 | 249.99 | 249.99 | 997,229 |
| Sep 11, 2026 | 248.05 | 254.08 | 246.01 | 248.68 | 248.68 | 1,177,421 |
| Sep 10, 2026 | 256.68 | 256.68 | 246.42 | 247.51 | 247.51 | 1,626,331 |
| Sep 9, 2026 | 257.07 | 261.98 | 253.28 | 258.00 | 258.00 | 1,426,414 |
| Sep 8, 2026 | 259.00 | 272.08 | 254.00 | 260.10 | 260.10 | 2,008,633 |
| Sep 4, 2026 | 258.58 | 266.85 | 258.02 | 266.11 | 266.11 | 1,431,221 |
| Sep 3, 2026 | 265.94 | 271.19 | 261.54 | 264.50 | 264.50 | 1,710,078 |
| Sep 2, 2026 | 246.48 | 269.94 | 246.48 | 267.40 | 267.40 | 3,286,329 |
| Sep 1, 2026 | 242.40 | 248.13 | 238.00 | 246.11 | 246.11 | 1,941,271 |
| Aug 31, 2026 | 235.94 | 243.02 | 233.33 | 240.69 | 240.69 | 1,636,349 |
| Aug 28, 2026 | 224.47 | 239.08 | 223.61 | 237.10 | 237.10 | 1,847,139 |
| Aug 27, 2026 | 236.56 | 238.00 | 230.46 | 236.56 | 236.56 | 1,293,542 |
| Aug 26, 2026 | 238.54 | 242.89 | 236.60 | 239.00 | 239.00 | 1,116,266 |
| Aug 25, 2026 | 236.56 | 240.67 | 235.41 | 240.08 | 240.08 | 1,576,352 |
| Aug 24, 2026 | 235.83 | 237.91 | 228.59 | 236.01 | 236.01 | 2,137,241 |
| Aug 21, 2026 | 228.88 | 238.97 | 228.34 | 236.22 | 236.22 | 1,906,404 |
| Aug 20, 2026 | 239.00 | 240.88 | 228.74 | 229.30 | 229.30 | 1,701,704 |
| Aug 19, 2026 | 234.36 | 244.03 | 233.40 | 242.61 | 242.61 | 1,879,215 |
| Aug 18, 2026 | 226.27 | 230.91 | 222.01 | 228.61 | 228.61 | 1,600,400 |
| Aug 17, 2026 | 225.76 | 227.99 | 222.12 | 224.60 | 224.60 | 1,539,238 |
| Aug 14, 2026 | 223.52 | 228.98 | 220.23 | 228.65 | 228.65 | 1,525,934 |
| Aug 13, 2026 | 225.95 | 227.54 | 222.70 | 227.12 | 227.12 | 1,449,424 |
| Aug 12, 2026 | 219.00 | 224.66 | 219.00 | 223.95 | 223.95 | 1,621,305 |
| Aug 11, 2026 | 217.41 | 223.44 | 216.50 | 221.20 | 221.20 | 1,438,183 |
| Aug 10, 2026 | 218.00 | 223.50 | 215.61 | 216.98 | 216.98 | 1,404,831 |
| Aug 7, 2026 | 217.31 | 219.64 | 210.49 | 219.20 | 219.20 | 1,735,992 |
| Aug 6, 2026 | 228.58 | 234.00 | 212.98 | 216.12 | 216.12 | 2,274,559 |
| Aug 5, 2026 | 221.74 | 229.65 | 221.50 | 228.72 | 228.72 | 2,734,599 |
| Aug 4, 2026 | 220.33 | 222.59 | 215.07 | 219.00 | 219.00 | 3,107,854 |
| Aug 3, 2026 | 208.03 | 220.49 | 208.03 | 220.33 | 220.33 | 3,400,184 |
| Jul 31, 2026 | 205.46 | 207.99 | 200.11 | 205.52 | 205.52 | 4,477,567 |
| Jul 30, 2026 | 225.02 | 230.00 | 197.81 | 205.48 | 205.48 | 9,835,843 |
| Jul 29, 2026 | 288.09 | 290.60 | 284.15 | 286.62 | 286.62 | 1,301,501 |
| Jul 28, 2026 | 282.79 | 290.47 | 281.23 | 288.41 | 288.41 | 1,437,745 |
| Jul 27, 2026 | 272.66 | 284.68 | 272.66 | 278.40 | 278.40 | 1,409,631 |
| Jul 24, 2026 | 268.74 | 275.58 | 265.64 | 271.77 | 271.77 | 1,151,029 |
| Jul 23, 2026 | 265.95 | 269.22 | 262.21 | 268.74 | 268.74 | 1,140,798 |
| Jul 22, 2026 | 270.84 | 273.71 | 264.21 | 266.99 | 266.99 | 1,104,662 |
| Jul 21, 2026 | 272.40 | 278.30 | 270.01 | 271.37 | 271.37 | 982,811 |
| Jul 20, 2026 | 267.55 | 275.25 | 266.27 | 272.67 | 272.67 | 1,359,742 |
| Jul 17, 2026 | 280.99 | 284.36 | 266.43 | 267.47 | 267.47 | 1,378,518 |
| Jul 16, 2026 | 279.64 | 286.60 | 273.78 | 283.15 | 283.15 | 1,436,413 |
| Jul 15, 2026 | 281.70 | 284.80 | 275.84 | 279.14 | 279.14 | 1,284,941 |
| Jul 14, 2026 | 283.55 | 286.75 | 279.43 | 281.26 | 281.26 | 1,093,297 |
| Jul 13, 2026 | 298.01 | 298.76 | 279.41 | 288.06 | 288.06 | 2,682,652 |
| Jul 10, 2026 | 314.71 | 322.49 | 293.78 | 298.76 | 298.76 | 2,538,292 |
| Jul 9, 2026 | 378.49 | 380.00 | 311.10 | 312.79 | 312.79 | 5,864,993 |
| Jul 8, 2026 | 318.50 | 325.37 | 316.77 | 323.50 | 323.50 | 897,702 |
| Jul 7, 2026 | 317.07 | 321.98 | 315.35 | 321.59 | 321.59 | 980,502 |
| Jul 6, 2026 | 319.34 | 319.34 | 307.13 | 313.04 | 313.04 | 891,867 |
| Jul 2, 2026 | 303.87 | 317.17 | 303.00 | 312.78 | 312.78 | 1,093,526 |
| Jul 1, 2026 | 304.54 | 309.27 | 301.50 | 301.67 | 301.67 | 1,070,648 |
| Jun 30, 2026 | 296.82 | 302.74 | 295.18 | 301.03 | 301.03 | 1,411,543 |
| Jun 29, 2026 | 296.97 | 298.27 | 291.90 | 293.52 | 293.52 | 1,367,343 |
| Jun 26, 2026 | 297.57 | 302.96 | 290.37 | 291.37 | 291.37 | 1,490,610 |
| Jun 25, 2026 | 293.68 | 298.35 | 290.06 | 293.17 | 293.17 | 1,128,203 |
| Jun 24, 2026 | 290.95 | 303.46 | 288.85 | 294.06 | 294.06 | 1,299,635 |
| Jun 23, 2026 | 290.89 | 291.95 | 285.26 | 288.18 | 288.18 | 1,087,832 |
| Jun 22, 2026 | 278.42 | 286.67 | 278.17 | 286.41 | 286.41 | 1,420,699 |
| Jun 18, 2026 | 280.11 | 282.98 | 273.11 | 278.09 | 278.09 | 2,204,703 |
| Jun 17, 2026 | 281.31 | 288.00 | 277.78 | 282.72 | 282.72 | 1,322,216 |
| Jun 16, 2026 | 288.13 | 288.48 | 276.94 | 281.90 | 281.90 | 1,213,288 |
| Jun 15, 2026 | 282.92 | 288.11 | 281.36 | 287.80 | 287.80 | 1,118,586 |
| Jun 12, 2026 | 288.96 | 291.28 | 281.76 | 282.85 | 282.85 | 1,420,050 |
| Jun 11, 2026 | 290.70 | 292.98 | 285.22 | 289.39 | 289.39 | 1,061,496 |
| Jun 10, 2026 | 297.69 | 299.70 | 290.53 | 291.22 | 291.22 | 927,374 |
| Jun 9, 2026 | 297.31 | 302.85 | 293.97 | 297.69 | 297.69 | 1,260,043 |
| Jun 8, 2026 | 303.11 | 303.57 | 285.54 | 292.16 | 292.16 | 1,651,435 |
| Jun 5, 2026 | 306.34 | 306.73 | 300.50 | 303.05 | 303.05 | 1,004,445 |
| Jun 4, 2026 | 297.22 | 310.53 | 293.85 | 303.64 | 303.64 | 1,081,496 |
| Jun 3, 2026 | 284.48 | 293.16 | 283.10 | 292.58 | 292.58 | 988,833 |
| Jun 2, 2026 | 293.94 | 295.60 | 285.00 | 286.12 | 286.12 | 1,042,633 |
| Jun 1, 2026 | 299.51 | 303.98 | 295.13 | 295.63 | 295.63 | 1,186,174 |
| May 29, 2026 | 302.43 | 305.68 | 297.62 | 301.98 | 301.98 | 2,278,069 |
| May 28, 2026 | 293.00 | 305.98 | 291.84 | 305.06 | 305.06 | 1,020,772 |
| May 27, 2026 | 293.40 | 299.98 | 292.91 | 295.63 | 295.63 | 629,519 |
| May 26, 2026 | 299.00 | 301.09 | 294.26 | 295.50 | 295.50 | 649,732 |
| May 22, 2026 | 299.12 | 303.33 | 294.99 | 297.45 | 297.45 | 681,308 |
| May 21, 2026 | 296.64 | 301.43 | 293.00 | 300.51 | 300.51 | 650,366 |
| May 20, 2026 | 297.80 | 300.08 | 292.10 | 298.48 | 298.48 | 799,240 |
| May 19, 2026 | 289.00 | 294.93 | 284.38 | 294.30 | 294.30 | 770,339 |
| May 18, 2026 | 287.14 | 291.97 | 285.26 | 286.27 | 286.27 | 873,361 |
| May 15, 2026 | 294.78 | 298.00 | 286.76 | 286.98 | 286.98 | 1,149,640 |
| May 14, 2026 | 290.72 | 297.00 | 287.51 | 293.45 | 293.45 | 889,670 |
| May 13, 2026 | 290.70 | 298.38 | 288.56 | 291.48 | 291.48 | 975,853 |
| May 12, 2026 | 288.66 | 295.86 | 286.73 | 292.03 | 292.03 | 826,171 |
| May 11, 2026 | 294.15 | 296.37 | 284.28 | 284.84 | 284.84 | 1,287,797 |
| May 8, 2026 | 295.91 | 300.17 | 293.06 | 295.05 | 295.05 | 926,772 |
| May 7, 2026 | 300.55 | 303.46 | 293.78 | 295.91 | 295.91 | 1,144,021 |
| May 6, 2026 | 301.57 | 306.03 | 298.96 | 303.00 | 303.00 | 1,012,334 |
| May 5, 2026 | 297.81 | 302.67 | 295.02 | 301.11 | 301.11 | 823,895 |
| May 4, 2026 | 298.00 | 300.49 | 288.06 | 297.93 | 297.93 | 1,590,519 |
| May 1, 2026 | 308.76 | 311.88 | 295.79 | 296.11 | 296.11 | 1,132,872 |
| Apr 30, 2026 | 307.48 | 317.56 | 287.00 | 309.49 | 309.49 | 2,192,132 |
| Apr 29, 2026 | 300.48 | 304.22 | 294.06 | 301.19 | 301.19 | 1,569,856 |
| Apr 28, 2026 | 308.97 | 314.17 | 301.80 | 302.11 | 302.11 | 996,287 |
| Apr 27, 2026 | 303.87 | 314.74 | 303.70 | 308.51 | 308.51 | 1,093,464 |
| Apr 24, 2026 | 309.63 | 311.10 | 302.89 | 305.54 | 305.54 | 825,633 |
| Apr 23, 2026 | 313.59 | 315.83 | 310.79 | 313.79 | 313.79 | 588,284 |
| Apr 22, 2026 | 308.43 | 312.69 | 307.85 | 310.58 | 310.58 | 1,003,730 |
| Apr 21, 2026 | 307.32 | 310.50 | 301.63 | 308.43 | 308.43 | 1,510,856 |
| Apr 20, 2026 | 306.56 | 312.25 | 305.00 | 310.94 | 310.94 | 966,541 |
| Apr 17, 2026 | 326.09 | 326.53 | 306.00 | 309.66 | 309.66 | 1,495,469 |
| Apr 16, 2026 | 333.39 | 333.39 | 318.93 | 320.13 | 320.13 | 1,022,841 |
| Apr 15, 2026 | 341.63 | 342.23 | 331.02 | 333.39 | 333.39 | 799,050 |
| Apr 14, 2026 | 330.81 | 343.36 | 330.54 | 339.41 | 339.41 | 1,228,645 |
| Apr 13, 2026 | 320.66 | 333.56 | 319.00 | 333.00 | 333.00 | 967,690 |
| Apr 10, 2026 | 323.49 | 328.93 | 317.53 | 322.11 | 322.11 | 698,672 |
| Apr 9, 2026 | 325.67 | 326.90 | 318.77 | 321.28 | 321.28 | 1,119,233 |
| Apr 8, 2026 | 327.49 | 330.30 | 324.44 | 327.25 | 327.25 | 1,024,695 |
| Apr 7, 2026 | 319.48 | 322.35 | 313.54 | 319.52 | 319.52 | 1,305,121 |
| Apr 6, 2026 | 320.10 | 335.58 | 320.10 | 330.34 | 330.34 | 1,276,806 |
| Apr 2, 2026 | 323.03 | 325.49 | 315.89 | 318.85 | 318.85 | 872,487 |
| Apr 1, 2026 | 332.69 | 335.48 | 327.59 | 328.73 | 328.73 | 673,304 |
| Mar 31, 2026 | 319.06 | 332.48 | 318.37 | 330.87 | 330.87 | 1,352,289 |
| Mar 30, 2026 | 319.32 | 321.76 | 314.20 | 316.09 | 316.09 | 1,223,904 |
| Mar 27, 2026 | 327.10 | 329.69 | 316.85 | 317.36 | 317.36 | 815,901 |
| Mar 26, 2026 | 328.90 | 332.81 | 327.69 | 328.16 | 328.16 | 1,119,781 |
| Mar 25, 2026 | 313.34 | 329.48 | 311.71 | 328.70 | 328.70 | 1,139,647 |
| Mar 24, 2026 | 303.42 | 308.91 | 299.62 | 308.05 | 308.05 | 1,497,337 |
| Mar 23, 2026 | 320.77 | 323.23 | 304.38 | 306.66 | 306.66 | 1,378,963 |
| Mar 20, 2026 | 311.05 | 322.43 | 311.05 | 312.17 | 312.17 | 2,050,765 |
| Mar 19, 2026 | 316.42 | 317.61 | 309.73 | 311.10 | 311.10 | 663,587 |
| Mar 18, 2026 | 317.50 | 319.27 | 312.58 | 314.80 | 314.80 | 1,077,650 |
| Mar 17, 2026 | 319.63 | 326.96 | 317.53 | 320.42 | 320.42 | 1,796,943 |
| Mar 16, 2026 | 311.22 | 319.55 | 311.22 | 318.91 | 318.91 | 1,247,482 |
| Mar 13, 2026 | 319.00 | 319.50 | 309.92 | 313.41 | 313.41 | 829,276 |
| Mar 12, 2026 | 320.53 | 321.00 | 309.61 | 317.23 | 317.23 | 1,247,315 |
| Mar 11, 2026 | 322.00 | 323.71 | 317.75 | 320.43 | 320.43 | 906,626 |
| Mar 10, 2026 | 325.60 | 326.18 | 317.03 | 322.38 | 322.38 | 1,169,417 |
| Mar 9, 2026 | 317.25 | 323.68 | 313.12 | 323.59 | 323.59 | 1,081,127 |
| Mar 6, 2026 | 317.73 | 321.17 | 312.09 | 320.66 | 320.66 | 996,497 |
| Mar 5, 2026 | 323.69 | 328.28 | 319.51 | 320.51 | 320.51 | 1,215,172 |
| Mar 4, 2026 | 319.20 | 328.00 | 317.25 | 327.30 | 327.30 | 931,151 |
| Mar 3, 2026 | 321.37 | 324.06 | 315.20 | 318.65 | 318.65 | 947,625 |
| Mar 2, 2026 | 329.41 | 334.42 | 323.16 | 325.07 | 325.07 | 1,302,332 |
| Feb 27, 2026 | 331.24 | 334.80 | 328.39 | 332.92 | 332.92 | 1,569,839 |
| Feb 26, 2026 | 328.67 | 333.47 | 322.00 | 331.24 | 331.24 | 880,311 |
| Feb 25, 2026 | 332.76 | 334.42 | 325.24 | 327.36 | 327.36 | 751,722 |
| Feb 24, 2026 | 328.22 | 333.06 | 324.48 | 332.85 | 332.85 | 791,573 |
| Feb 23, 2026 | 335.73 | 341.38 | 326.76 | 329.35 | 329.35 | 792,033 |
| Feb 20, 2026 | 336.58 | 345.89 | 335.83 | 336.19 | 336.19 | 1,375,285 |
| Feb 19, 2026 | 332.24 | 339.61 | 326.33 | 339.37 | 339.37 | 1,152,962 |
| Feb 18, 2026 | 328.86 | 335.80 | 324.53 | 332.68 | 332.68 | 1,151,205 |
| Feb 17, 2026 | 316.80 | 336.21 | 315.62 | 332.61 | 332.61 | 1,516,389 |
| Feb 13, 2026 | 302.55 | 318.44 | 302.55 | 314.40 | 314.40 | 1,476,326 |
| Feb 12, 2026 | 314.42 | 315.51 | 298.00 | 308.48 | 308.48 | 2,897,726 |
| Feb 11, 2026 | 322.14 | 325.04 | 317.80 | 322.28 | 322.28 | 1,582,249 |
| Feb 10, 2026 | 322.68 | 325.98 | 317.89 | 322.98 | 322.98 | 1,865,664 |
| Feb 9, 2026 | 325.49 | 329.92 | 319.26 | 320.00 | 320.00 | 1,392,019 |
| Feb 6, 2026 | 331.61 | 340.07 | 326.51 | 328.16 | 328.16 | 1,476,914 |
| Feb 5, 2026 | 350.50 | 350.50 | 327.27 | 331.24 | 331.24 | 2,620,979 |
| Feb 4, 2026 | 354.00 | 355.49 | 347.08 | 351.96 | 351.96 | 1,779,461 |
| Feb 3, 2026 | 338.49 | 352.82 | 337.59 | 351.80 | 351.80 | 2,152,860 |
| Feb 2, 2026 | 337.42 | 342.33 | 333.00 | 339.11 | 339.11 | 1,911,150 |
| Jan 30, 2026 | 343.10 | 346.50 | 336.39 | 338.06 | 338.06 | 1,648,568 |
| Jan 29, 2026 | 349.37 | 350.34 | 345.01 | 346.79 | 346.79 | 1,682,030 |
| Jan 28, 2026 | 353.66 | 356.84 | 348.00 | 349.58 | 349.58 | 1,099,190 |
| Jan 27, 2026 | 361.55 | 368.07 | 354.69 | 354.75 | 354.75 | 988,087 |
| Jan 26, 2026 | 357.98 | 364.07 | 352.50 | 361.35 | 361.35 | 936,370 |
| Jan 23, 2026 | 368.20 | 371.33 | 356.72 | 357.98 | 357.98 | 1,636,801 |
| Jan 22, 2026 | 365.50 | 376.87 | 363.36 | 370.00 | 370.00 | 1,875,372 |
| Jan 21, 2026 | 353.01 | 366.00 | 351.55 | 365.46 | 365.46 | 1,523,470 |
| Jan 20, 2026 | 350.70 | 355.74 | 347.76 | 355.53 | 355.53 | 1,722,679 |
| Jan 16, 2026 | 362.29 | 367.20 | 355.46 | 359.27 | 359.27 | 1,527,370 |
| Jan 15, 2026 | 368.54 | 372.82 | 356.83 | 359.26 | 359.26 | 911,176 |
| Jan 14, 2026 | 369.95 | 371.71 | 359.95 | 366.86 | 366.86 | 1,250,044 |
| Jan 13, 2026 | 369.10 | 376.88 | 366.92 | 369.96 | 369.96 | 1,625,677 |
| Jan 12, 2026 | 377.82 | 378.61 | 353.52 | 370.91 | 370.91 | 3,808,067 |
| Jan 9, 2026 | 399.40 | 409.57 | 392.56 | 398.29 | 398.29 | 1,440,224 |
| Jan 8, 2026 | 420.18 | 425.19 | 393.48 | 399.40 | 399.40 | 1,400,657 |
| Jan 7, 2026 | 405.51 | 427.05 | 405.51 | 422.50 | 422.50 | 1,426,278 |
| Jan 6, 2026 | 396.23 | 409.18 | 384.42 | 406.40 | 406.40 | 1,612,994 |
| Jan 5, 2026 | 397.57 | 400.00 | 383.84 | 397.83 | 397.83 | 1,093,965 |
| Jan 2, 2026 | 399.34 | 407.22 | 396.08 | 400.17 | 400.17 | 730,517 |
| Dec 31, 2025 | 397.25 | 402.44 | 397.25 | 397.65 | 397.65 | 768,860 |
| Dec 30, 2025 | 394.81 | 398.40 | 393.64 | 397.25 | 397.25 | 504,789 |
| Dec 29, 2025 | 400.10 | 402.72 | 397.05 | 398.82 | 398.82 | 638,375 |
| Dec 26, 2025 | 404.58 | 404.58 | 397.31 | 400.59 | 400.59 | 401,455 |
| Dec 24, 2025 | 395.99 | 401.47 | 395.05 | 400.69 | 400.69 | 408,233 |
| Dec 23, 2025 | 404.72 | 407.43 | 395.99 | 398.70 | 398.70 | 792,295 |
| Dec 22, 2025 | 409.60 | 413.59 | 403.20 | 407.73 | 407.73 | 1,052,983 |
| Dec 19, 2025 | 399.11 | 408.15 | 395.97 | 400.23 | 400.23 | 12,576,505 |
| Dec 18, 2025 | 394.49 | 404.19 | 391.51 | 396.04 | 396.04 | 1,714,954 |
| Dec 17, 2025 | 394.18 | 400.24 | 389.00 | 392.10 | 392.10 | 1,041,476 |
| Dec 16, 2025 | 390.65 | 399.64 | 388.54 | 391.17 | 391.17 | 1,345,516 |
| Dec 15, 2025 | 394.22 | 402.33 | 390.00 | 391.50 | 391.50 | 1,483,326 |
| Dec 12, 2025 | 408.86 | 410.04 | 387.03 | 397.55 | 397.55 | 1,659,227 |
| Dec 11, 2025 | 403.36 | 414.22 | 402.22 | 412.63 | 412.63 | 1,284,788 |
| Dec 10, 2025 | 416.54 | 417.00 | 403.80 | 404.46 | 404.46 | 1,188,960 |
| Dec 9, 2025 | 430.45 | 433.31 | 412.31 | 415.21 | 415.21 | 1,610,475 |
| Dec 8, 2025 | 447.00 | 449.78 | 423.45 | 430.02 | 430.02 | 2,411,635 |
| Dec 5, 2025 | 468.29 | 473.50 | 455.32 | 458.12 | 458.12 | 627,353 |
| Dec 4, 2025 | 472.67 | 477.06 | 463.03 | 465.34 | 465.34 | 983,982 |
| Dec 3, 2025 | 466.49 | 479.79 | 460.41 | 473.29 | 473.29 | 1,092,993 |
| Dec 2, 2025 | 453.90 | 472.48 | 453.00 | 464.93 | 464.93 | 1,204,115 |
| Dec 1, 2025 | 450.00 | 462.93 | 448.26 | 454.56 | 454.56 | 1,070,657 |
| Nov 28, 2025 | 448.18 | 455.75 | 444.43 | 451.23 | 451.23 | 563,871 |
| Nov 26, 2025 | 432.87 | 447.69 | 430.27 | 445.12 | 445.12 | 908,163 |
| Nov 25, 2025 | 436.84 | 441.82 | 428.57 | 429.80 | 429.80 | 1,009,228 |
| Nov 24, 2025 | 439.46 | 444.67 | 420.30 | 434.23 | 434.23 | 1,750,352 |
| Nov 21, 2025 | 448.23 | 449.53 | 433.50 | 436.38 | 436.38 | 1,298,052 |
| Nov 20, 2025 | 463.32 | 467.73 | 445.34 | 445.79 | 445.79 | 787,662 |
| Nov 19, 2025 | 462.27 | 465.32 | 456.90 | 460.76 | 460.76 | 893,894 |
| Nov 18, 2025 | 458.15 | 469.11 | 456.27 | 462.30 | 462.30 | 668,666 |
| Nov 17, 2025 | 449.00 | 463.92 | 449.00 | 460.54 | 460.54 | 962,080 |
| Nov 14, 2025 | 453.87 | 461.96 | 448.28 | 449.16 | 449.16 | 968,547 |
| Nov 13, 2025 | 450.67 | 456.14 | 447.12 | 453.97 | 453.97 | 798,910 |
| Nov 12, 2025 | 450.63 | 459.27 | 446.71 | 452.74 | 452.74 | 937,690 |
| Nov 11, 2025 | 443.53 | 455.20 | 441.21 | 451.95 | 451.95 | 981,717 |
| Nov 10, 2025 | 445.00 | 449.68 | 440.93 | 441.70 | 441.70 | 739,044 |
| Nov 7, 2025 | 437.81 | 443.69 | 430.83 | 442.70 | 442.70 | 822,669 |
| Nov 6, 2025 | 431.78 | 445.50 | 429.00 | 440.49 | 440.49 | 700,509 |
| Nov 5, 2025 | 422.11 | 438.53 | 417.00 | 434.56 | 434.56 | 974,550 |
| Nov 4, 2025 | 429.90 | 431.50 | 421.83 | 423.47 | 423.47 | 1,170,232 |
| Nov 3, 2025 | 454.58 | 457.26 | 429.60 | 434.07 | 434.07 | 1,556,549 |
| Oct 31, 2025 | 449.00 | 459.77 | 441.22 | 456.04 | 456.04 | 1,817,670 |
| Oct 30, 2025 | 450.00 | 472.36 | 436.51 | 449.56 | 449.56 | 2,313,994 |
| Oct 29, 2025 | 475.19 | 482.73 | 467.09 | 481.59 | 481.59 | 1,360,223 |
| Oct 28, 2025 | 476.50 | 484.61 | 473.29 | 475.91 | 475.91 | 836,305 |
| Oct 27, 2025 | 465.56 | 485.36 | 465.55 | 478.58 | 478.58 | 1,174,680 |
| Oct 24, 2025 | 468.68 | 469.29 | 459.38 | 463.43 | 463.43 | 771,302 |
| Oct 23, 2025 | 464.71 | 468.86 | 456.90 | 464.00 | 464.00 | 683,376 |
| Oct 22, 2025 | 477.66 | 480.53 | 461.21 | 464.90 | 464.90 | 950,023 |
| Oct 21, 2025 | 488.42 | 490.05 | 471.40 | 474.00 | 474.00 | 826,254 |
| Oct 20, 2025 | 476.82 | 495.55 | 476.82 | 491.22 | 491.22 | 950,011 |
| Oct 17, 2025 | 481.65 | 492.62 | 476.44 | 481.67 | 481.67 | 1,029,195 |
| Oct 16, 2025 | 474.39 | 488.38 | 470.46 | 481.07 | 481.07 | 964,728 |
| Oct 15, 2025 | 469.19 | 485.28 | 467.50 | 470.27 | 470.27 | 1,475,359 |
| Oct 14, 2025 | 462.13 | 479.69 | 457.73 | 469.36 | 469.36 | 1,435,825 |
| Oct 13, 2025 | 456.13 | 473.65 | 453.82 | 464.95 | 464.95 | 1,579,240 |
| Oct 10, 2025 | 460.28 | 460.60 | 451.00 | 460.46 | 460.46 | 937,064 |
| Oct 9, 2025 | 451.00 | 459.57 | 448.83 | 456.95 | 456.95 | 1,051,960 |
| Oct 8, 2025 | 464.46 | 464.46 | 449.72 | 450.68 | 450.68 | 929,883 |
| Oct 7, 2025 | 456.94 | 462.63 | 448.95 | 459.58 | 459.58 | 791,895 |
| Oct 6, 2025 | 458.69 | 458.69 | 449.92 | 452.00 | 452.00 | 918,501 |
| Oct 3, 2025 | 465.00 | 465.00 | 448.47 | 456.35 | 456.35 | 969,089 |
| Oct 2, 2025 | 457.64 | 461.53 | 446.18 | 460.99 | 460.99 | 1,269,237 |
| Oct 1, 2025 | 456.00 | 467.42 | 453.31 | 460.65 | 460.65 | 1,370,050 |
| Sep 30, 2025 | 445.22 | 459.30 | 445.22 | 456.00 | 456.00 | 1,379,551 |
| Sep 29, 2025 | 448.00 | 451.63 | 446.30 | 447.49 | 447.49 | 719,079 |
| Sep 26, 2025 | 453.05 | 453.05 | 442.51 | 446.40 | 446.40 | 812,999 |
| Sep 25, 2025 | 457.03 | 459.00 | 446.42 | 449.58 | 449.58 | 685,313 |
| Sep 24, 2025 | 454.35 | 462.69 | 450.97 | 458.37 | 458.37 | 975,991 |
| Sep 23, 2025 | 452.83 | 457.47 | 450.50 | 454.41 | 454.41 | 1,024,608 |
| Sep 22, 2025 | 453.56 | 462.88 | 450.23 | 458.92 | 458.92 | 971,763 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
Need daily prices for every ticker, in code?
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver API
Alnylam Pharmaceuticals, Inc. Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at ALNY, per a recent SEC DEF 14A filing. We estimate that the median employee at ALNYLAM PHARMACEUTICALS, INC. is paid $297,040.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|